calendar
5,573 catalysts · 5,256 phase readout · 2,309 8k filing · 315 pdufa · 259 earnings · 2 approval · 1 adcom
next 91 dayslessmore
MonWedFri
5,573 catalysts · 5,256 phase readout · 2,309 8k filing · 315 pdufa · 259 earnings · 2 approval · 1 adcom
Sponsor: Oxford University Clinical Research Unit, Vietnam. Phase: PHASE3. Conditions: Dengue, Severe Dengue, Mosquito-Borne Diseases, Vector Borne Diseases, Arbovirus Infections, Flavivirus Infections, RNA Virus Infections, Hemorrhagic Fever
Sponsor: Emory University. Phase: NA. Conditions: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Head and Neck Carcinoma of Unknown Primary, Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma, Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell Carcinoma, Metastatic Laryngeal Squamous Cell Carcinoma, Metastatic Nasopharyngeal Squamous Cell Carcinoma, Metastatic Oral Cavity Squamous Cell Carcinoma, Metastatic Oropharyngeal Squamous Cell Carcinoma, Metastatic Paranasal Sinus Squamous Cell Carcinoma, Nasopharyngeal Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma, Paranasal Sinus Squamous Cell Carcinoma, Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Nasopharyngeal Squamous Cell Carcinoma, Recurrent Oral Cavity Squamous Cell Carcinoma, Recurrent Oropharyngeal Squamous Cell Carcinoma, Recurrent Paranasal Sinus Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8, Stage IV Hypopharyngeal Carcinoma AJCC v8, Stage IV Laryngeal Cancer AJCC v8, Stage IV Lip and Oral Cavity Cancer AJCC v8, Stage IV Nasopharyngeal Carcinoma AJCC v8, Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IV Sinonasal Cancer AJCC v8
Sponsor: Supira Medical. Phase: NA. Conditions: Heart Diseases, Coronary Artery Disease (CAD), Heart Failure
Sponsor: Universidad de Zaragoza. Phase: NA. Conditions: Type 2 Diabetes, Overweight or Obesity, PreDiabetes
Sponsor: University Hospital Hradec Kralove. Phase: PHASE2. Conditions: Ischemic Stroke
Sponsor: Mayo Clinic. Phase: NA. Conditions: Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
Sponsor: Takeda. Phase: . Conditions: Dengue Fever
Sponsor: Dartmouth-Hitchcock Medical Center. Phase: NA. Conditions: Autism Spectrum Disorder, PTSD and Trauma-related Symptoms, Autism, Trauma and Stressor Related Disorders, Mental Health Services
Sponsor: VisionCare, Inc.. Phase: NA. Conditions: Age - Related Macular Degeneration (AMD)
Sponsor: Imperial College London. Phase: NA. Conditions: Influenza
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Immunity, Humoral
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia. Phase: . Conditions: Liver Steatosis
Sponsor: Defense and Veterans Center for Integrative Pain Management. Phase: . Conditions: Post Surgical Pain and Sleep Impairment
Sponsor: Dr. Chris McGlory, PhD. Phase: NA. Conditions: Sarcopenia, Aging, Frailty
Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.. Phase: PHASE3. Conditions: HER2-positive Breast Cancer
Sponsor: University Hospital, Strasbourg, France. Phase: PHASE3. Conditions: Akathisia
Sponsor: Keymed Biosciences Co.Ltd. Phase: PHASE1. Conditions: Primary Sjögren's Syndrome (pSS)
Sponsor: Izmir Democracy University. Phase: NA. Conditions: Central Sensitisation, Cervical Spine Stenosis
Sponsor: Azafaros B.V.. Phase: PHASE3. Conditions: Niemann-Pick Type C Disease, GM1 Gangliosidosis, GM2 Gangliosidosis
Sponsor: Mingjian Ge. Phase: NA. Conditions: VATS, Lung Hernia
Sponsor: University of Wisconsin, Madison. Phase: PHASE3. Conditions: Brain Metastasis, Radiation Therapy, Immunotherapy, Active
Sponsor: Chinese University of Hong Kong. Phase: NA. Conditions: Acute Cholecystitis
Sponsor: Kelley-Ross & Associates, Inc.. Phase: PHASE4. Conditions: HIV
Sponsor: NovoBliss Research Pvt Ltd. Phase: NA. Conditions: Dry and Sensitive Skin
Sponsor: Novartis Pharmaceuticals. Phase: . Conditions: Asthma
Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Aging, Musculoskeletal Diseases, Osteoporosis
Sponsor: Health Services Academy, Islamabad, Pakistan. Phase: NA. Conditions: HbA1c, Self-Efficacy, Diabetes Knowledge
Sponsor: Medtronic MiniMed, Inc.. Phase: NA. Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
Sponsor: Menoufia University. Phase: NA. Conditions: Change in Serum Levels of the Estimated Inflammatory Cytokines, Total Dose of IO Fentanyl, PO Morphine, Surgeons' Rating, Pain Scores
Sponsor: Southeast University, China. Phase: . Conditions: Shock
Sponsor: Sanofi. Phase: PHASE1. Conditions: COVID-19 Immunization, Influenza Immunization
Sponsor: Cedars-Sinai Medical Center. Phase: PHASE2. Conditions: REM Sleep Behavior Disorder, Pre-motor Parkinson's Disease, Symptomatic Parkinson Disease
Sponsor: Orthofix s.r.l.. Phase: . Conditions: Deformity, Defect, Congenital, Trauma
Sponsor: Massachusetts General Hospital. Phase: PHASE2. Conditions: Vascular Inflammation, ASCVD, ASCVD Management
Sponsor: University Hospital, Brest. Phase: NA. Conditions: Coxarthrosis; Primary, Coxarthrosis; Secondary
Sponsor: Airiver Medical, Inc.. Phase: NA. Conditions: Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Sponsor: St. Anne's University Hospital Brno, Czech Republic. Phase: . Conditions: Post-Op Complication
Sponsor: Aston University. Phase: NA. Conditions: Dry Eye Syndromes, Computer Vision Syndrome
Sponsor: Shaklee Corporation. Phase: NA. Conditions: Healthy Adult
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, de Novo Myelodysplastic Syndrome, High Risk Myelodysplastic Syndrome, Inv(16), Myelodysplastic Syndrome With Excess Blasts, t(16;16), t(8;21), Untreated Adult Acute Myeloid Leukemia
Sponsor: University of Michigan. Phase: PHASE4. Conditions: Surgical Prophylaxis
Sponsor: Jiangsu HengRui Medicine Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumors
Sponsor: Affiliated Hospital of Nantong University. Phase: PHASE1. Conditions: Relapsed/Refractory B-cell Lymphoma
Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: IDH1 wt Allele, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Malignant Glioma
Sponsor: Istanbul University - Cerrahpasa. Phase: PHASE4. Conditions: Cardiac Surgery Patient, Postoperative Pain, Pain After Surgery
Sponsor: Mastelli S.r.l. Phase: NA. Conditions: Aesthetic Improvement of the Skin, Skin Hydration in Healthy Volunteers, Skin Elasticity, Skin Turgor, Subject Satisfaction
Sponsor: Bern University of Applied Sciences. Phase: NA. Conditions: Obesity & Overweight, Emotional Eating Behaviour, Mindful Eating Intervention
Sponsor: Elazıg Fethi Sekin Sehir Hastanesi. Phase: NA. Conditions: Diabetic Retinopathy, Diabetes Mellitus, Retinal Microvascular Disease
Sponsor: Bio-Thera Solutions. Phase: PHASE1. Conditions: Carcinoma, Non-Small-Cell Lung
Sponsor: University Hospitals Cleveland Medical Center. Phase: PHASE2. Conditions: Non-Alcoholic Fatty Liver Disease (NAFLD)